President Museveni has congratulated Dr. Misaki Wayengera, a Researcher at Makerere University College of Health Sciences, for his efforts in developing a rapid test kit to diagnose the deadly Ebola and Marburg viruses. Dr Wayengera is an EDCTP Career Development Fellow (TMA2016CDF1545).
“I want to congratulate our scientists because they are really waking up and producing a lot of products. The Government will fund you. It is the issue of prioritization and putting the money in the right place,” he said. The President was on Tuesday speaking during a meeting at State House, Entebbe to recognize Dr. Misaki Wayengera who recently won the World Health Organization (WHO) high innovation challenge in Product Development Category that took place at the WHO Africa Regional Headquarters in Congo (Brazzaville).
Dr Wayengera’s invention also known as Pan-Filovirus Rapid Diagnostic Test, uses a paper-strip test, like the one used in testing for pregnancy. This, however, will be used in detecting Ebola, Marburg and other hemorrhagic fevers. Africa has had several hemorrhagic fever outbreaks especially Ebola Virus Disease (EVD) with the latest and ongoing outbreak currently in the Democratic Republic of Congo that borders Uganda to the West. Rapid diagnosis is important in informing key decisions especially interventions and measures to take in the event of a disease outbreak. If approved by health authorities including the World Health Organization (WHO) and partners, Dr Wayengera’s Pan-Filovirus Rapid Diagnostic Test will go a long way in improving rapid tests and turnaround time for results during disease outbreaks. President Museveni said that the Government of Uganda will support the efforts of the researchers by establishing a manufacturing facility that will enable them to put all the products together. He commended Dr. Wayengera and his team on the achievements realized adding that the research can bring in a host of benefits to society because the products form the core that addresses many human challenges such as hemorrhage fevers and HIV afflictions that immensely affect the world. The President observed that Uganda has, on several occasions, been attacked by epidemics, including Ebola and Marburg, resulting in the deaths of trained preventive workers and wananchi. State Minister for Health, Hon. Sarah Ochieng Opendi, saluted Dr. Wayengera and his team for the innovation saying their efforts will go a long way in easing the diagnosis of viral hemorrhage fevers such as Ebola and Marburg. Dr. Wayengera, on his part, thanked President Museveni for recognizing their efforts and his support.
EDCTP Career Development Fellow Dr Virginie Rozot, a research officer at the South African Tuberculosis Vaccine Initiative (SATVI), has been awarded a multi‑year contract under Wellcome Leap’s Delta Tissue (∆T) programme. Her research will investigate how the human immune system responds to Mycobacterium tuberculosis in the thoracic lymph nodes, and why these responses sometimes fail, allowing the bacteria to spread to other organs. The findings are expected to inform future TB vaccine design and vaccination strategies.
Global Health EDCTP3 is now inviting applications for the EDCTP Prizes 2027, recognising outstanding individuals and research teams from Africa and Europe for their achievements in global health research and innovation.
The 2027 edition will award four prize categories, highlighting excellence in scientific leadership, collaborative team research, and gender-balanced scientific contributions. Prize winners will be announced at the EDCTP Forum 2027 in Madrid, Spain. Submissions are open until 2 September 2026.
Global Health EDCTP3 has opened the calls for abstracts, scientific symposia and workshops for the EDCTP Forum 2027, one of the leading global health research events focused on infectious diseases in sub-Saharan Africa. The deadline for submissions is 2 September 2026 at 17:00 (Brussels time).
Under the theme ‘Innovating together for resilient global health', the 13th edition of the EDCTP Forum, taking place from 5-9 April 2027 in Madrid, Spain, will offer researchers, policymakers, funders and implementers the opportunity to showcase their work at a flagship global health event.
The Forum offers a unique platform to share research findings, build partnerships and help shape discussions on global health priorities. Currently, submissions for abstracts, scientific symposia and workshops are open.